新天綠色能源(00956.HK)完成發行10.4億元2021年可續期綠色公司債
格隆匯 3 月 11日丨新天綠色能源(00956.HK)發佈公吿,公司已於2021年3月10日完成公司2021年可續期綠色公司債券(第一期)發行。該期債券的實際發行規模為人民幣10.4億元,以每3個計息年度為1個週期,在每個週期末,公司有權選擇將本期債券期限延長1個週期,或選擇在該週期末到期全額兑付該期債券。該期債券單位面值為人民幣100元,票面利率為5.15%。利息自2021年3月10日起開始計算。
該期債券由銀河證券、中信證券及光大證券作為主承銷商公開發售,募集資金用於償還到期的綠色債券和與綠色主營業務相關的其他債務,綠色產業項目建設、運營、收購以及補充流動資金等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.